House Dust Mite Induced Inflammasome Activation on Corticosteroid Resistance
NCT03307278 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL
Last updated 2021-08-02
Summary
In this project, PBMCs will be isolated from HDM allergic and non allergic patient and then stimulated with HDM crude extract. The expression of inflammasome and the correlation of inflammasome activation and steroid resistance will be investigated.
Conditions
- Allergic Asthma
Interventions
- BIOLOGICAL
-
House dust mite
As a stimulant to induce inflammasome activation
Sponsors & Collaborators
-
China Medical University Hospital
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 20 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2017-11-30
- Primary Completion
- 2018-09-06
- Completion
- 2018-09-06
More Related Trials
-
Study of Dust Mite Inhalation in Humans
NCT00448851 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety Trial of Pangramin SLIT HDM-mix in Subjects With House Dust Mite Induced Rhinitis
NCT01603056 ·Status: COMPLETED ·Phase: PHASE3
-
House Dust Mite Allergy Trial In Children
NCT04145219 ·Status: COMPLETED ·Phase: PHASE3
-
A Research Study in Chinese People With Allergy to House Dust Mites, Using an Environmental Exposure Chamber
NCT04176185 ·Status: TERMINATED ·Phase: PHASE3
-
Comparative Evaluation of Safety and Immune Activity of New Immunotherapeutic Agents for HDM Allergic Rhinitis Patients
NCT05525650 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE1
-
An Optional Investigation of Biomarkers of Efficacy
NCT01949415 ·Status: COMPLETED
-
The Effect of FP-025, on Allergen-induced Airway Responses in Mild Eosinophilic House Dust Mite (HDM)-Allergic Asthma.
NCT03858686 ·Status: COMPLETED ·Phase: PHASE2
-
ToleroMune House Dust Mite Follow on Study
NCT01923792 ·Status: COMPLETED
-
Impact of a Novel Immune Modulating Dietary Supplement on House Dust Mite Induced Allergic Rhinoconjunctivitis
NCT04477382 ·Status: COMPLETED
-
A Study to Assess the Safety, Tolerability and Immunological Response of ASP2390 in Adult Subjects Allergic to House Dust Mites
NCT04184895 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Dose Ranging Study of SLIT Tablets of House Dust Mite Allergen Extracts (HDM) in Adults With HDM-associated Allergic Asthma
NCT01930461 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of an Immunotoxin on Activated Human Macrophages in Those With Allergic Rhinitis or Mild Intermittent Asthma
NCT00295737 ·Status: TERMINATED ·Phase: NA
-
A Randomized, Double-Blind, Placebo-Controlled, Multi-Centre Study to Assess the Efficacy of PURETHAL Mites Mixture 50,000 AUeq/mL Subcutaneous Immunotherapy in Adult Subjects With Moderate to Severe Allergic Rhinitis/Rhinoconjunctivitis With or Without Asthma Induced by House Dust Mite (HDM)
NCT06920771 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Efficacy and Safety Trial of the ALK HDM Tablet in House Dust Mite Allergic Subjects
NCT00389363 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
House Dust Mite Treatment of Asthma. The MITRA Trial House Dust Mite Treatment of Asthma
NCT01433523 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy & Safety of STG320 Sublingual Tablets of HDM Allergen Extracts in Adults and Adolescents With HDM-associated AR
NCT02443805 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of 100IR, 300IR, 500IR Sublingual House Dust Mite Tablets in Allergic Rhinitis Environment Exposure Chamber Model
NCT01527188 ·Status: COMPLETED ·Phase: PHASE2
-
Impact of Carrier Solutions for House Dust Mite Allergen on Allergic Reactions
NCT05245175 ·Status: COMPLETED ·Phase: NA
-
Effects of Tregalizumab on Allergen-induced Airway Responses and Airway Inflammation in Asthmatic Patients
NCT04673591 ·Status: COMPLETED ·Phase: PHASE2
-
Mechanisms of Allergen Immunotherapy
NCT00001910 ·Status: COMPLETED
-
Evaluation of Nasal Mucosal Permeability in Controls and House Dust Mite Allergic Rhinitis Patients
NCT02461797 ·Status: COMPLETED ·Phase: NA
-
A Multi-centered,Randomized,Double-blind,Placebo-controlled Study to Evaluate the Efficacy and Safety of SHR-1703 in Eosinophilic Asthma
NCT06653322 ·Status: RECRUITING ·Phase: PHASE3
-
A Phase III Study to Assess Efficacy and Safety of STALORAL® 300 IR Sublingual Immunotherapy (SLIT) in Asthmatic Patients Allergic to House-dust Mites
NCT00660452 ·Status: COMPLETED ·Phase: PHASE3
-
Acupuncture for Rhinitis Complicated With Asthma
NCT02033252 ·Status: UNKNOWN ·Phase: NA
-
Validation of an Environmental Exposure Chamber for Inhalation Studies With House Dust Mite Allergen in Patients With Allergic Rhinitis
NCT01275456 ·Status: COMPLETED ·Phase: NA